Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SM04554 in Male Subjects With Androgenetic Alopecia
NCT02503137Phase 2Completed
- Sponsor
- Biosplice Therapeutics
- Start
- Aug 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dalosirvat in androgenetic alopecia (AGA), sponsored by Biosplice Therapeutics. Started Aug 2015; status: completed.
02
Drugs
dalosirvat
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT02503137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02503137.